# A Two-Part Study to Determine: Best Medication Formulation and Food Effect

> **NCT00427596** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 18 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Solabegron

## Key facts

- **NCT ID:** NCT00427596
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2008-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427596, "A Two-Part Study to Determine: Best Medication Formulation and Food Effect". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00427596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*